A Smart Wearable Device for Monitoring Urination Function in Benign Prostatic Hyperplasia
An Intelligent Wearable Device Based on Electrical Impedance Tomography for Dynamic and Accurate Monitoring of Voiding Function in Patients With Benign Prostatic Hyperplasia
1 other identifier
observational
40
1 country
1
Brief Summary
Benign Prostatic Hyperplasia (BPH) is a common condition that can cause bothersome urination problems and reduce quality of life. Accurately measuring how the bladder empties is important for diagnosis and treatment, but current methods like uroflowmetry can be inconvenient and are done only at a clinic. This study aims to test a new, non-invasive smart wearable device that uses Electrical Impedance Tomography (EIT) to monitor bladder function in patients with BPH. The device is worn on the lower abdomen. In this study, participants will use this EIT device while also undergoing the standard uroflowmetry test. The main goal is to see how well the measurements from the new device (like urine flow rate and volume) agree with those from the standard test. The study hopes to show that this wearable device can accurately and comfortably track bladder function over time. If successful, it could lead to a new tool for doctors to better monitor patients with BPH, even potentially at home.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2026
CompletedStudy Start
First participant enrolled
January 15, 2026
CompletedFirst Posted
Study publicly available on registry
January 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
January 21, 2026
January 1, 2026
2 years
January 12, 2026
January 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Agreement of Voiding Parameters Between EIT Device and Uroflowmetry
From device placement until completion of the voiding test, assessed on the day of the single study visit.
Study Arms (1)
Benign Prostatic Hyperplasia (BPH) Patients
Interventions
A non-invasive, portable device that uses an array of surface electrodes placed on the lower abdomen to measure bioimpedance changes. It reconstructs real-time, three-dimensional images and volume data of the bladder during filling and voiding phases.
Eligibility Criteria
Adult male patients diagnosed with BPH who are scheduled for urodynamic evaluation
You may qualify if:
- Patients with BPH who need urodynamic tests to further evaluate the underlying pathophysiology of LUTS prior to invasive treatment.
- Patients who understand and agree with the written informed consent, and voluntary to participate in the study.
You may not qualify if:
- Patients with catheter-dependent urinary retention. Patients who cannot void \> 150ml. Patients with uncontrolled acute urinary tract infections. Patients who suffer from severe mental illness or other diseases that may affect judgment or cooperation during the study.
- Patients with implanted cardiac pacemaker or other electronic implants that may potentially be interfered by the EIT device.
- Patients with other conditions who are deemed unsuitable for participation by the investigator.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University Third Hospital
Beijing, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liu Zhuo
Peking University Third Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 12, 2026
First Posted
January 21, 2026
Study Start
January 15, 2026
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
July 1, 2028
Last Updated
January 21, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share